WASATCH ADVISORS LP 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-08 1:11 pm Sale | 2024-03-08 | 13G | C4 Therapeutics, Inc. CCCC | WASATCH ADVISORS LP | 5,516,718 8.000% | -1,622,231 (-22.72%) | Filing |
| 2024-02-09 1:04 pm Purchase | 2024-02-09 | 13G | C4 Therapeutics, Inc. CCCC | WASATCH ADVISORS LP | 7,138,949 14.500% | 1,363,251 (+23.60%) | Filing |
| 2023-02-08 3:42 pm Purchase | 2023-02-08 | 13G | C4 Therapeutics, Inc. CCCC | WASATCH ADVISORS LP | 5,775,698 11.800% | 789,626 (+15.84%) | Filing |
| 2022-06-06 1:31 pm Purchase | 2022-06-06 | 13G | C4 Therapeutics, Inc. CCCC | WASATCH ADVISORS LP | 4,986,072 10.200% | 4,986,072 (New Position) | Filing |